Abstract
Introduction: This systematic review and meta-analysis aims to explore the influence of ferumoxytol versus placebo on iron deficiency anemia. Methods: We search for randomized controlled trials (RCTs) assessing the effect of ferumoxytol on iron deficiency anemia on PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases. This meta-analysis is performed using the random-effects model. Results: Four RCTs are included in the meta-analysis. Compared with the control group for iron deficiency anemia, intravenous ferumoxytol can significantly improve the proportion of patients with a ≥20 g/L hemoglobin (Hb) increase (RR = 18.43; 95% CI = 7.29–46.57; p < 0.00001), the proportion of patients with an Hb level ≥120 g/L (RR = 18.55; 95% CI = 8.66–39.72; p < 0.00001), transferrin saturation (mean difference = 11.08; 95% CI = 9.86–12.31; p < 0.00001) and FACIT-fatigue score (mean difference = 4.60; 95% CI = 3.21–6.00; p < 0.00001), but has no remarkable influence on adverse events (RR = 1.33; 95% CI = 0.84–2.10; p = 0.22), serious adverse events (RR = 1.22; 95% CI = 0.74–2.02; p = 0.44), and death (RR = 0.32; 95% CI = 0.05–1.95; p = 0.22). Conclusions: Intravenous ferumoxytol can provide the important benefits for iron deficiency anemia.
References
1.
Chertow
GM
, Block
GA
, Neylan
JF
, Pergola
PE
, Uhlig
K
, Fishbane
S
. Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
. PLoS One
. 2017
Nov
;12
(11
):e0188712
.
[PubMed]
1932-62032.
Stein
J
, Aksan
A
, Farrag
K
, Dignass
A
, Radeke
HH
. Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice
. Expert Opin Pharmacother
. 2017
Nov
;18
(16
):1721
–37
.
[PubMed]
1465-65663.
Laso-Morales
M
, Jericó
C
, Gómez-Ramírez
S
, Castellví
J
, Viso
L
, Roig-Martínez
I
, et al. Preoperative management of colorectal cancer-induced iron deficiency anemia in clinical practice: data from a large observational cohort
. Transfusion
. 2017
Dec
;57
(12
):3040
–8
.
[PubMed]
0041-11324.
Bou-Fakhredin
R
, Halawi
R
, Roumi
J
, Taher
A
. Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease
. Expert Rev Hematol
. 2017
Sep
;10
(9
):801
–8
.
[PubMed]
1747-40865.
Miller
JL
. Iron deficiency anemia: a common and curable disease
. Cold Spring Harb Perspect Med
. 2013
Jul
;3
(7
):3
.
[PubMed]
2157-14226.
Majid
S
, Salih
M
, Wasaya
R
, Jafri
W
. Predictors of gastrointestinal lesions on endoscopy in iron deficiency anemia without gastrointestinal symptoms
. BMC Gastroenterol
. 2008
Nov
;8
(1
):52
.
[PubMed]
1471-230X7.
Carter
D
, Levi
G
, Tzur
D
, Novis
B
, Avidan
B
. Prevalence and predictive factors for gastrointestinal pathology in young men evaluated for iron deficiency anemia
. Dig Dis Sci
. 2013
May
;58
(5
):1299
–305
.
[PubMed]
0163-21168.
Ghosh-Jerath
S
, Singh
A
, Jerath
N
, Gupta
S
, Racine
EF
. Undernutrition and severe acute malnutrition in children
. BMJ
. 2017
Nov
;359
:j4877
.
[PubMed]
0959-81389.
Qamar
K
, Saboor
M
, Qudsia
F
, Khosa
SM
, Moinuddin
, Usman
M
. Malabsorption of iron as a cause of iron deficiency anemia in postmenopausal women
. Pak J Med Sci
. 2015
Mar-Apr
;31
(2
):304
–8
.
[PubMed]
1682-024X10.
Liu
K
, Kaffes
AJ
. Iron deficiency anaemia: a review of diagnosis, investigation and management
. Eur J Gastroenterol Hepatol
. 2012
Feb
;24
(2
):109
–16
.
[PubMed]
0954-691X11.
Iadevaia
MD
, Sgambato
D
, Miranda
A
, Ferrante
E
, Federico
A
, Sasso
FC
, et al. Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia
. Acta Gastroenterol Belg
. 2017
Apr-Jun
;80
(2
):327
–8
.
[PubMed]
1784-322712.
Tomkins
S
, Chapman
C
, Myland
M
, Tham
R
, de Nobrega
R
, Jackson
B
, et al. Treating iron deficiency in patients with gastrointestinal disease: risk of re-attendance in secondary care
. PLoS One
. 2017
Dec
;12
(12
):e0189952
.
[PubMed]
1932-620313.
Bang
SM
, Lee
JO
, Kim
YJ
, Lee
KW
, Lim
S
, Kim
JH
, et al. Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA)
. Ann Hematol
. 2013
Jan
;92
(1
):59
–65
.
[PubMed]
0939-555514.
Ando
K
, Morita
S
, Higashi
T
, Fukuhara
S
, Watanabe
S
, Park
J
, et al. Health-related quality of life among Japanese women with iron-deficiency anemia
. Qual Life Res
. 2006
Dec
;15
(10
):1559
–63
.
[PubMed]
0962-934315.
Larson
LM
, Phiri
KS
, Pasricha
SR
. Iron and Cognitive Development: What Is the Evidence?
Ann Nutr Metab
. 2017
;71
Suppl 3
:25
–38
.
[PubMed]
0250-680716.
Elli
L
, Ferretti
F
, Branchi
F
, Tomba
C
, Lombardo
V
, Scricciolo
A
, et al. Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study
. Nutrients
. 2018
Mar
;10
(3
):10
.
[PubMed]
2072-664317.
Stein
J
, Haas
JS
, Ong
SH
, Borchert
K
, Hardt
T
, Lechat
E
, et al. Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - a real-world evidence analysis
. Clinicoecon Outcomes Res
. 2018
Feb
;10
:93
–103
.
[PubMed]
1178-698118.
Adkinson
NF
, Strauss
WE
, Macdougall
IC
, Bernard
KE
, Auerbach
M
, Kaper
RF
, et al. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
. Am J Hematol
. 2018
May
;93
(5
):683
–90
.
[PubMed]
0361-860919.
Adkinson
NF
, Strauss
WE
, Bernard
K
, Kaper
RF
, Macdougall
IC
, Krop
JS
. Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
. J Blood Med
. 2017
Sep
;8
:155
–63
.
[PubMed]
1179-273620.
Dahl
NV
, Kaper
RF
, Strauss
WE
, Corvino
FA
, Zivkovic
M
. Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
. Clinicoecon Outcomes Res
. 2017
Sep
;9
:557
–67
.
[PubMed]
1178-698121.
Hassan
N
, Boville
B
, Reischmann
D
, Ndika
A
, Sterken
D
, Kovey
K
. Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency Anemia
. Ann Pharmacother
. 2017
Jul
;51
(7
):548
–54
.
[PubMed]
1060-028022.
Ford
DC
, Dahl
NV
, Strauss
WE
, Barish
CF
, Hetzel
DJ
, Bernard
K
, et al. Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
. Clin Exp Gastroenterol
. 2016
Jul
;9
:151
–62
.
[PubMed]
1178-702323.
Vadhan-Raj
S
, Dahl
NV
, Bernard
K
, Li
Z
, Strauss
WE
. Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
. J Blood Med
. 2017
Dec
;8
:199
–209
.
[PubMed]
1179-273624.
Vadhan-Raj
S
, Strauss
W
, Ford
D
, Bernard
K
, Boccia
R
, Li
J
, et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
. Am J Hematol
. 2014
Jan
;89
(1
):7
–12
.
[PubMed]
0361-860925.
Moher
D
, Liberati
A
, Tetzlaff
J
, Altman
DG
, Group
P
; PRISMA Group
. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
. J Clin Epidemiol
. 2009
Oct
;62
(10
):1006
–12
.
[PubMed]
0895-435626.
Jadad
AR
, Moore
RA
, Carroll
D
, Jenkinson
C
, Reynolds
DJ
, Gavaghan
DJ
, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials
. 1996
Feb
;17
(1
):1
–12
.
[PubMed]
0197-245627.
Kjaergard
LL
, Villumsen
J
, Gluud
C
. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses
. Ann Intern Med
. 2001
Dec
;135
(11
):982
–9
.
[PubMed]
0003-481928.
Higgins
JP
, Thompson
SG
. Quantifying heterogeneity in a meta-analysis
. Stat Med
. 2002
Jun
;21
(11
):1539
–58
.
[PubMed]
0277-671529.
Singh
A
, Patel
T
, Hertel
J
, Bernardo
M
, Kausz
A
, Brenner
L
. Safety of ferumoxytol in patients with anemia and CKD
. Am J Kidney Dis
. 2008
Nov
;52
(5
):907
–15
.
[PubMed]
0272-638630.
Kulnigg
S
, Gasche
C
. Systematic review: managing anaemia in Crohn’s disease
. Aliment Pharmacol Ther
. 2006
Dec
;24
(11-12
):1507
–23
.
[PubMed]
0269-281331.
Schröder
O
, Mickisch
O
, Seidler
U
, de Weerth
A
, Dignass
AU
, Herfarth
H
, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease—a randomized, controlled, open-label, multicenter study
. Am J Gastroenterol
. 2005
Nov
;100
(11
):2503
–9
.
[PubMed]
0002-927032.
Van Assche
G
, Dignass
A
, Bokemeyer
B
, Danese
S
, Gionchetti
P
, Moser
G
, et al.; European Crohn’s and Colitis Organisation
. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations
. J Crohn’s Colitis
. 2013
Feb
;7
(1
):1
–33
.
[PubMed]
1873-994633.
Holm
C
, Thomsen
LL
, Langhoff-Roos
J
. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2018
:1-8. 34.
Estadella
J
, Villamarín
L
, Feliu
A
, Perelló
J
, Calaf
J
. Characterization of the population with severe iron deficiency anemia at risk of requiring intravenous iron supplementation
. Eur J Obstet Gynecol Reprod Biol
. 2018
May
;224
:41
–4
.
[PubMed]
0301-211535.
Laso-Morales
MJ
, Vives
R
, Gomez-Ramirez
S
, Pallisera-Lloveras
A
, Pontes
C
. Intravenous iron administration for post-operative anaemia management after colorectal cancer surgery in clinical practice: a single-centre, retrospective study.
Blood transfusion = Trasfusione del sangue. 2018
:1-5.36.
Koutroubakis
IE
, Oustamanolakis
P
, Karakoidas
C
, Mantzaris
GJ
, Kouroumalis
EA
. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease
. Dig Dis Sci
. 2010
Aug
;55
(8
):2327
–31
.
[PubMed]
0163-2116© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
